Benolea (Olea europaea)

Benolea is a standardized olive leaf extract containing 15-20% oleuropein, a phenolic compound with antioxidant properties. The extract works primarily through oleuropein's ability to scavenge free radicals and modulate inflammatory pathways.

Origin & History

Benolea is a branded olive leaf extract standardized to 15-20% oleuropein, derived from the leaves of Olea europaea L., a Mediterranean olive tree. It is produced using high-pressure extraction methods such as pressurized liquid extraction (PLE) with ethanol at 60°C or supercritical fluid extraction (SFE) with CO₂, yielding phenolic content up to 386 mg GAE/g extract.

Historical & Cultural Context

The research provided no information on traditional or historical medicinal uses of olive leaves or Benolea specifically.

Health Benefits

• No human clinical trials specifically for Benolea were identified in the research
• General olive leaf extracts contain phenolic compounds with potential health properties (evidence quality: not established for Benolea)
• Standardized oleuropein content (15-20%) suggests possible antioxidant activity (evidence quality: theoretical based on chemical composition)
• High phenolic content (up to 386 mg GAE/g) may offer protective effects (evidence quality: based on extraction data only)
• Contains bioactive compounds like hydroxytyrosol and luteolin found in olive leaves (evidence quality: chemical analysis only)

How It Works

Benolea's primary bioactive compound oleuropein acts as a potent antioxidant by donating hydrogen atoms to neutralize free radicals. Oleuropein also modulates nuclear factor-kappa B (NF-κB) signaling pathways, potentially reducing inflammatory cytokine production. The standardized phenolic content may support cellular protection through activation of antioxidant enzyme systems.

Scientific Research

No human clinical trials, RCTs, or meta-analyses for Benolea were found in the research. The available data focuses exclusively on extraction methods and phytochemical profiles, with no PubMed PMIDs identified for branded Benolea studies.

Clinical Summary

No human clinical trials have been conducted specifically on Benolea as a branded ingredient. Research on general olive leaf extracts suggests potential benefits, but these studies used different formulations and standardization levels. The evidence quality for Benolea's health effects remains not established due to lack of specific clinical investigation. Most olive leaf extract studies used doses ranging from 500-1000mg daily with varying oleuropein concentrations.

Nutritional Profile

Benolea is a proprietary standardized olive leaf extract (Olea europaea), not a whole food ingredient, so macronutrient and micronutrient framing is less applicable than bioactive compound profiling. Key bioactive compounds: Oleuropein standardized at 15-20% concentration (150-200mg/g extract), representing the primary secoiridoid glycoside. Total phenolic content reported up to 386 mg gallic acid equivalents per gram (386 mg GAE/g), placing it among high-potency polyphenol extracts. Additional identified phenolic constituents include hydroxytyrosol (a primary metabolite of oleuropein hydrolysis, present at variable concentrations typically 1-5% in standardized extracts), tyrosol, luteolin, apigenin, caffeic acid, and verbascoside (acteoside). Elenolic acid is present as a hydrolysis byproduct of oleuropein. Flavonoid subfractions include rutin and quercetin derivatives. As an extract concentrate, conventional macronutrients (fat, carbohydrate, protein) are present only in trace or excipient-level amounts depending on final formulation. Fiber content is negligible in extract form. Bioavailability notes: Oleuropein undergoes intestinal hydrolysis to hydroxytyrosol, which demonstrates superior bioavailability (~55-75% absorbed) compared to intact oleuropein; absorption is enhanced with lipid co-ingestion; peak plasma concentrations of hydroxytyrosol typically reached within 1-2 hours post-ingestion. Mineral content not meaningfully documented for this extract form.

Preparation & Dosage

No clinically studied dosage ranges for Benolea are available as human trials are absent. Extraction studies indicate oleuropein yields of 73.6-106.5 mg/g, but no branded product dosing has been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified in research

Safety & Interactions

Benolea safety profile has not been established through specific clinical testing. General olive leaf extracts are typically well-tolerated but may cause mild gastrointestinal upset in some individuals. Potential interactions with blood pressure medications and diabetes drugs should be considered due to olive leaf's reported effects on these parameters. Pregnant and nursing women should avoid use due to insufficient safety data.